AMAAYA™ Antiaging & Wellness Clinic led by Obesity & Anti-Aging Consultant Dr. Deepak Chaturvedi also recognized as “India’s Most Promising Anti- aging & Wellness Clinic 2014” for innovation in Medical Research & quality medical care
Noted Mumbai based Obesity & Anti-Aging Consultant & Expert in Management of Obesity, Andropause, Menopause, Sexual dysfunction, Aging and Other Hormonal Issues Dr. Deepak Chaturvedi was crowned as “India’s Most Promising Obesity Consultant 2014” at the Asia’s Biggest & Nation’s most awaited healthcare summit & Awards organized by healthcare communication leader Pharmaleaders ( www.pharmaleader.tv ) , the 7th Annual Pharmaceutical L:eadership Summit & Pharmaleaders Business Leadership Awards 2014 ( www.pharmaleaders2014.com ) held in Mumbai on 26th December 2014 at Hotel Sahara Star, Mumbai, India.
Pharmaleaders, Asia’s most analytical news media in healthcare communications successfully organized the 7th Annual Pharmaceutical Leadership Summit & Pharma Leaders Business Leaders Awards 2014 under the theme “Make In India – Healthcare Reforms, Insurance,Innovations,Investments & Infrastructure – “Empowering India’s Developing Healthcare System” – Investing the Healthcare Solutions of Tomorrow in difficult Times. The top Healthcare leaders of the country addressed at the 300 plus power packed audience comprising of the pharmaceutical & biotechnology industry owners, Medical Experts, Policy makers & Academic Research Scientists. Prominent speakers included Prof. (Dr) V.Mohan, CMD & Chief Diabetologist, Dr. Mohan’s Diabetes Specialties Centre, Dr.K.S.Murthy, Chief Cardiac Surgeon & Chairman, Innova Children’s Heart Hospital, Prof. Dr. Deepak K Jumani Consultant Sexual Health Physician and Counselor, Mr. Ajit. Singh, Chairman, ACG Worldwide, Mr. Satya Brahma, Chairman & Editor-In-Chief, Pharmaleaders (A Division of Network 7 Media Group), Mr. Daara Patel, Secretary General, IDMA ( Indian Drug Manufacturers Association), Mr. Ashok jain, MD & CEO at Oxygen Healthcare Communication etc. The Highlight of the Summit was a well conceived Panel Discussion on “The New Age Medical Profession – Patient Centered Care” – Of the patients, For the Patients & By the Patients with Prof. Dr. Chandrasekar Chikkamuniyappa, CEO, & Senior Joint Replacement Surgeon, People Tree Hospitals., Dr. Ruby Tandon, CEO, Afterglow Laser Clinic, Prof. Dr. Shashank R Joshi, Consultant Diabetologist, Joshi’s Clinic., Dr.Ajayita Chanana & Founder, CEO, Dr. Ajayita’s Charak Ayurvedic Clinic, Prof. Dr Deepak K Jumani, Consultant Sexual Health Physician and Counselor , Dr.Deepak Chaturvedi, Physician Endocrinologist, Obesity & Anti-aging Consultant, Dr. Manaan Gandhi, Ayurveda Consultant, Panchakarma Clinic ,. Prof. Dr Deepak K Jumani, Consultant Sexual Health Physician and Counselor, Dr. Sandeep Chatrath, Chief Executive Officer, Dharamshila Hospital And Research Centre
Mr. Ajit Singh, Chairman of the Associated Capsules Group also known as ACG World Wide conferred the prestigious award to Dr. Deepak in the presence of Mr Satya Brahma of Pharmaleaders Group.
Pharmaleaders 2014 power brand awards were conferred to the successful Pharma Leaders & Medical Professionals in a sold out gala Dinner where who’s & who’s of the india healthcare industry were present. Addressing the Award Winners, Satya Brahma, Chairman & Editor-In-Chief of Pharma Leaders said “Pharmaleaders Power Brand Awards are the most prestigious annual industry awards recognized annually that acknowledge and honor individuals and organizations for their remarkable accomplishments. These are fitting tribute to those individuals and companies that have gone the extra mile to advance the excellence in healthcare through best practices and leadership, Pharmaleaders Business Leadership Awards is the premier largest business and technology leadership awards program in the sub continent , covering the set of prestigious awards spanning from biotech to Healthcare to CEO awards”. Pharma Leaders Power Brand Awards are conferred to those Companies & Individuals who exhibt rare display of innovation for Outstanding Academic & Professional Leadership to individuals & Companies This top recognition symbolizes the best out of best from chosen few, Satya added.
Dr. Deepak Chaturvedi’s Achievements
Diabetes Thyroid & Hormone Clinic ™ (DTHC) is a dedicated clinic to manage Diabetes Mellitus, Obesity and Other Endocrine (Hormonal) problems under one roof. Almost, all functions of the body are directly or indirectly dependent on a healthy Endocrine (Hormone) system. Hence, a healthy Endocrine (Hormone) system is key to healthy living. The clinical cases of the Endocrine diseases (Like Diabetes Mellitus, Hypothyroidism, Addison’s Disease etc) are only the tip of the iceberg. Majority of the population is suffering from the subclinical cases. These cases need to be identified and treated before the frank disease appears. Endocrine Diseases (including Diabetes Mellitus) usually present as constellation of medical problems (syndromes).Commonly, more than one endocrine organ is involved leading to a cascade of hormonal imbalances disturbing the homeostasis and leading to various diseases.Having long standing vague symptoms like Fatigue, Lethargy, Mood disturbances, Low libido, Weight gain, Weight loss, losing muscle mass, Foggy thinking, Amotivation etc. are strong clues towards the underlying hormonal issues and should call for hormones evaluation.To address these needs, Dr. Deepak formed Diabetes Thyroid & Hormone Clinic™ (DTHC) which is a dedicated unit to give patients & ailing families a healthy and productive life.
Dr. Deepak Chaturvedi is a renowned Physician Endocrinologist, Diabetologist, Antiaging Specialist and Obesity Consultant is also an expert in Management of Obesity, Andropause, Menopause, Sexual dysfunction, Aging and Other Hormonal Issues.Dr. Deepak Chaturvedi is Physician Endocrinologist, Diabetologist, Antiaging Specialist and Bariatrician based in Mumbai with clientele from all over the globe. He is the co-founder and Medical director of “Antiaging Medicine And Research (AMAR)” AND “INDOMEDICON”; the Society and Conference forum associated with the awareness of Age Management and Hormone Corrective Therapies. He is a leading Antiaging Physician in India.Dr.Deepak Chaturvedi is part of the advisory board of various clinics national as well as international.His area of expertise include management of various endocrinologic conditions such as Obesity , Diabetes , Thyroid dysfunction , PCOD , Menopause , Andropause , Sexual Dysfunction (in men and women) , Metabolic and Immunologic conditions and other hormonal imbalances and AGING.
SEMINARS / CONFERENCES / WORKSHOPS CONDUCTED
HIV awareness program/Lectures in various Medical and Non Medical colleges and Community.
The “Art and Science Of Anti-aging Medicine” (in association with Indian Medical Association, Mumbai) at IMA House, Haji Ali, Mumbai in February – 2008
Workshop on “Practice of Anti-aging Medicine” at Hotel Taj Lands End , Mumbai in May – 2008
INDOMEDICON the first ever “Conference cum Certification Course in Anti- Aging Medicine” (in association with Anti-aging Medicine And Research (AMAR) – India and World Society of Anti-aging Medicine (WOSAAM)) at Hotel Le Meridian, Mumbai in December – 2009.
INDOMEDICON: 2010 at Hotel Imperial Palace – Mumbai, India in June 2010
INDOMEDICON: 2011 at Hotel Tivoli Garden Resorts- New Delhi in May 2011
INDOMEDICON: 2013 – 4th Conference for Antiaging, Lifespan and Integrative Medicine to be held at Hilton Hotel and Resorts, Mumbai on 23rd and 24th of February 2013.
Delivered a lecture on “Antiaging Medicine: A novel approach” in B.J.Medical College, Pune, India, which is one of the leading tertiary care centre in India.
Introduced Antiaging Medicine Concept in the minds of the Medical fraternity at Government Medical College, Solapur, India recently through an interactive lecture session on Antiaging.
INDOMEDICON: 2014 – 5th Antiaging Medicine And Research Conference
to be held at Hotel Holiday Inn, Andheri (E), Mumbai on 14th, 15th and 16th February, 2014.
Given lectures at various other Antiaging Conferences/CMEs/Workshops
nationally as well as internationally.
Conducting regular workshops (At least 6 Seminars/workshop per year) in Antiaging Medicine for the physicians under “Antiaging Medicine And Research (AMAR)” since year 2008.
OTHER ACADEMIC ASSOCIATION / PROJECTS
Assisted Dr.Thierry Hertoghe for his books on Hormone Therapy, Thalassotherapy , Oxytocin , Phytohormones.
Editing and Compiling of Literature material in INDOMEDICON 2010 (Step 1 and Step 2).
Preparing Question papers for various Antiaging Course Examination.
Currently working on a chapter on “Hormones in Skin and Aesthetic Practice” for a “Textbook of Dermatology”.
Coming up with a “Continuing Medical Education Program in Antiaging & Regenerative Medicine” in association with Indian Medical Association.
Attachments and Affiliations
Founder and Secretary : Antiaging Medicine And Research (AMAR): The Society for Antiaging Medicine.
President : INDOMEDICON : The Antiaging Conferences and Training Body.
Vice-President : World Anti-Aging Network (WAAN)
Member : World Society of Antaging Medicine.
Medical Director : Amari Rejuvenation Clinics Pvt Ltd.
Medical Director : Atpomed Medicines India Pvt Ltd.
Medical Director and Advisor : Age Management Medicine And Research India Pvt Ltd.
Life Member : Association of Medical Consultants, Mumbai.
Life Member : Indian Medical Association.
Founder and Consultant : AMAAYA™ Antiaging & Wellness Clinic, Mumbai.
Scientific Advisor and Consultant : AMAYA™ Clinic, USA.
Co-Founder and Consultant : Diabetes, Thyroid & Hormone Clinic™ , Mumbai.
Consultant : AMAAYA™ Antiaging & Wellness Clinic.
Consultant : Life Alive, Chennai.
Trustee : Mauli Seva Pratisthan.
Consultant At :
AMAAYA™ Antiaging & Wellness Clinic :
amaayaclinic.com , firstname.lastname@example.org
Diabetes, Thyroid & Hormone Clinic™ , Mumbai :
dthc.in , email@example.com
AMAYA™ Clinic, USA :
amayaclinic.com , firstname.lastname@example.org
Awarded as the “Incredible Medical Expert of the Decade” by “The
Pharma leaders” on 27th December 2013 at Mumbai.
Awarded as “India’s Most Promising Antiaging Specialist” at “India Leadership Conclave” on 18th July 2014 at Mumbai.
Awarded the “Achievement Award-2014” by Newspaper Association of India (NAI) on 31st October 2014 at New Delhi.
Awarded as “India’s Most Promising Obesity Consultant and Best Antiaging Clinic” in Pharma Leaders Award on 26th Dec 2014 at Sahara Star Hotel Mumbai.
Lifespan Clinic India, with a specialized 28 Clinics in india is the World’s largest chain of Clinics in Diabetes-Cardiometabolic awarded at Asia’s Biggest Healthcare Summit the 7th Annual Pharmaceutical Leadership Summit & Business Leadership Awards for its dedicated vision of dreaming a World without Diabetes.
Lifespan Clinic India was voted & Awarded at the Asia’s biggest meeting point of the healthcare professionals at the 7th Annual edition of the Pharmaleaders Power Brand Awards 2014 where the theme was focusing on “Make In India, Healthcare Reforms, Insurance,Innovations,Investments & Infrastructure” & Empowering India’s Developing Healthcare System – Investing the Healthcare Solutions of Tomorrow in difficult Times on December,26th , 2014 at Hotel Sahara Star, Mumbai International Airport in Mumbai, India.
Mr. Ajit Singh, Chairman of the Associated Capsules Group also known as ACG World Wide conferred the prestigious award title to Mr. Ashok Jain, CEO & MD of Lifespan Clinic India in the presence of Mr Satya Brahma of Pharmaleaders Group. Pharmaleaders, Asia’s most analytical news media in healthcare communications successfully organized the 7th Annual Pharmaceutical Leadership Summit & Pharma Leaders Business Leaders Awards 2014 under the theme “Make In India – Healthcare Reforms, Insurance,Innovations,Investments & Infrastructure – “Empowering India’s Developing Healthcare System” – Investing the Healthcare Solutions of Tomorrow in difficult Times. The top Healthcare leaders of the country addressed at the 300 plus power packed audience comprising of the pharmaceutical & biotechnology industry owners, Medical Experts, Policy makers & Academic Research Scientists. Prominent speakers included Prof. (Dr) V.Mohan, CMD & Chief Diabetologist, Dr. Mohan’s Diabetes Specialties Centre, Dr.K.S.Murthy, Chief Cardiac Surgeon & Chairman, Innova Children’s Heart Hospital, Prof. Dr. Deepak K Jumani Consultant Sexual Health Physician and Counselor, Mr. Ajit. Singh, Chairman, ACG Worldwide, Mr. Satya Brahma, Chairman & Editor-In-Chief, Pharmaleaders (A Division of Network 7 Media Group), Mr. Daara Patel, Secretary General, IDMA ( Indian Drug Manufacturers Association), Mr. Ashok jain, MD & CEO at Oxygen Healthcare Communication etc. The Highlight of the Summit was a well conceived Panel Discussion on “The New Age Medical Profession – Patient Centered Care” – Of the patients, For the Patients & By the Patients with Prof. Dr. Chandrasekar Chikkamuniyappa, CEO, & Senior Joint Replacement Surgeon, People Tree Hospitals., Dr. Ruby Tandon, CEO, Afterglow Laser Clinic, Prof. Dr. Shashank R Joshi, Consultant Diabetologist, Joshi’s Clinic., Dr.Ajayita Chanana & Founder, CEO, Dr. Ajayita’s Charak Ayurvedic Clinic, Prof. Dr Deepak K Jumani, Consultant Sexual Health Physician and Counselor , Dr.Deepak Chaturvedi, Physician Endocrinologist, Obesity & Anti-aging Consultant, Dr. Manaan Gandhi, Ayurveda Consultant, Panchakarma Clinic ,. Prof. Dr Deepak K Jumani, Consultant Sexual Health Physician and Counselor, Dr. Sandeep Chatrath, Chief Executive Officer, Dharamshila Hospital And Research Centre
In the award letter addressed to Mr. Ashok Jain, M D & CEO of Oxygen Healthcare Communications which spearheads the life support to the Lifespan Clinic India’s strategic planning, Mr. Satya Brahma, Editor-In-Chief of Pharmaleaders Group said “ The Organizing Committee of the 7th Annual Pharmaceutical Leadership Summit & Pharma Leaders™ Business Leadership Awards 2014, rated & widely acclaimed by the industry experts & analysts as a credible award platform known for selecting top leaders through a meticulous methodology & stringent selection process involving research inputs & credible voting process by noted eminent juries is India’s Only Dedicated Celebration Of Excellence In Healthcare Innovation, Pharmaceutical & Medical Excellence And Brand Transformation. Pharma Leaders™ has selected Lifespan Clinic for the prestigious recognition because of its innovation in brining a different perspectives in the field of Diabetes-Cardiometabolic care ”.
Pharmaleaders Group since its inception in 1999, has so far awarded 400 top Pharma Entrepreneurs, Medical Professionals, Research Scientists & Government Academia. The debut of Lifespan Clinic in the Winners library at Pharmaleaders Power Brand is a rare distinction as the award is conferred for its ability to bring awareness in a largely populated country like india. “The Primary factor that propelled the Jury is to look at the forward looking vision of the company coupled with the risk taking abilities & the visionary Leadership of steering the company in the complex business of healthcare where each day we are witnessing new competition, bigger challenges & ability to stay ahead of competition. Looking at the growing demands for a personalized care in Diabetes, your foray into the franchise business in the form of a massive growth plan to set up unique & specialized centre coupled with aggressive marketing in bringing awareness is indeed noteworthy. India is home to nearly 62 million diabetics – second only to China which has over 92 million diabetics. By 2030, India’s diabetes numbers are expected to cross the 100 million mark according to a 2012 report by International Diabetes Federation. The economic burden due to diabetes in India is among the highest in the world. Over 30 million have now been diagnosed with diabetes in India. The CPR (Crude prevalence rate) in the urban areas of India is thought to be 9 per cent.In rural areas, the prevalence is approximately 3 per cent of the total population.The population of India is now more than 1000 million: this helps to give an idea of the scale of the problem.The estimate of the actual number of diabetics in India is around 40 million.This means that India actually has the highest number of diabetics of any one country in the entire world. IGT (Impaired Glucose Tolerance) is also a mounting problem in India.The prevalence of IGT is thought to be around 8.7 per cent in urban areas and 7.9 per cent in rural areas, although this estimate may be too high. It is thought that around 35 per cent of IGT sufferers go on to develop type 2 diabetes, so India is genuinely facing a healthcare crisis”.
Lifespan is India’s largest chain of comprehensive diabetes and metabolic clinics. In a very short span of time, Lifespan has managed to establish itself as a specialized center for the treatment and management of diabetes and metabolic disorders.Lifespan began its mission of providing full care for people suffering from diabetes and metabolic disorders on 2nd September, 2013. Within such a short time, Lifespan has had more than 15,000 patient interactions
Birth of Lifespan Clinic India
The founder of Lifespan is Ashok Jain. On 24th October 1995, Ashok Jain was pronounced a diabetic with a reading of 429 mg/DL. Nineteen years of struggles and discoveries have inspired him with the vision of Lifespan Diabetes and Metabolic Clinics – a chain to help and support people like himself. To plan for, and operate this chain, Ashok draws upon his extensive experience in initiating and managing all-India franchise operations. He had earlier worked in a MNC food company in senior management positions for two decades before venturing 13 years ago to found Oxygen Healthcare and subsequently goodhealthandyou.com.Ashok’s own tribulations with diabetes and those of his various family members caused him to grapple with the question of how control over diabetes could be achieved. His work in the Healthcare field brought him in close contact with doctors, pharma companies, and patients.
What Lifespan Clinic Is All About?
Lifespan is a caring endeavour that brings in a new level of organised support and state-of-the-art medicare for the treatment and management of chronic diseases such as diabetes.It introduces standardised quality across its chain of Lifespan Clinics across the country offering ample client support and implementing the latest approaches and technologies for the benefit of its clients. Lifespan Clinic is India’s first chain of comprehensive diabetes management centres. A part of Oxygen Group of Companies. Lifespan is a caring endeavour that brings in a new level of organized support and state-of-the-art Medicare for the treatment and management of chronic diseases such as diabetes. Standardized quality across its chain of Lifespan Clinics across the country offering ample support and implementing the latest approaches and technologies for the benefit of people. Lifespan empathizes with, and strongly encourages people to lead healthier, more productive and longer lives. We are now functional in 4 major cities in India; Mumbai, Bengaluru, Hyderabad and Ahmedabad. Oxygen Media Services Pvt. Ltd. is India’s largest integrated Lifestyle and Wellness marketing company in India, promoted by well-known names from the marketing and advertising field.
13 years experience with health and nutrition brands along with doctors & consumers.
Marketing services partner for 50 top healthcare companies.
Working with more than 1 lakh doctors.
Database of 2 lakh doctors.
We empathise with, and strongly encourage our clients to lead healthier, more productive and longer lives.You can expect from Lifespan :
An individualised management plan based on your unique lifestyle, dietary habits, nature of work, family history, personal medical history and current fitness.
Unified solution with expertise, diagnostics and guidance under one convenient roof. Easy-to-access electronic medical records.
A support system working in multiple modes to advise and arrange various means of support to diabetics.
Uniformity of standards followed across clinics that are designed to maximise convenience, therapy effectiveness and continuity of client support.
Head Office of 80 people at Worli Seaface Mumbai, across creative, marketing, a medical team consisting of doctors, technical and editing team.
7 Branch offices and force of 100 Regional Officers in top 15 cities across India.
What’s unique about the concept of Lifespan Clinics?
Lifespan Clinic offers India’s first Comprehensive Diabetes Management Programme. We bring in a whole new level of organized support and care through the use of state-of-the-art medicare for the treatment and management of diabetes. Eighteen years of struggles and discoveries have inspired me to have the vision of Lifespan Clinics – a chain to help and support people affected by diabetes. And, also prediabetics, of whom there are a huge number in this country.
Why a special clinic only for Diabetics and Pre-diabetics?
India is emerging as the diabetes capital of the world. Statistics are that we are nearing 10 Crore diabetics and 20 Crore pre-diabetics. Though the number of diabetics is increasing, we saw the limitations in the treatment options available to a diabetic. In order to address this need, we decided to start a chain of Lifespan Clinics that could offer comprehensive treatment and provide a unified solution with expertise, diagnosis and guidance under one roof for pre-diabetes and diabetes care.
How come such a large number of diabetics and cases of pre-diabetes are said to go undetected? Is this a risk?
This is because of the nature of diabetes, it shows no tell-tale or attention-getting symptoms and that’s the reason it has been termed a `silent killer’. It has caused organ damage and affected important systems in your body even by the time you are declared diabetic. People think it is bothersome to go for blood tests with fasting, but there is hope that with easier and simpler methods such as our Lifespan Clinic’s R.I.S.C test, many more of them will be screened early.
If a person has excess body weight, comes from a family where any of the parents or siblings are diabetic, or have hypertension, have a highly sedentary occupation as well as personal life – it would be foolhardy to not get tested for diabetes. If they are identified early to be diabetic, this will save them from the severe complications associated with diabetes.
How do you differentiate Lifespan Clinics from other clinics or a specialty hospital where a Diabetic could get treated?
At a stand-alone healthcare clinic, the expertise is scattered and no two consultations are the same. Time also is a constraint. Lifespan Clinics offers a unique approach to treating diabetes. We prepare an individualised management plan that takes into consideration the patient’s lifestyle, dietary habits, nature of work, family work, personal medical history and current fitness.
We give patients a unified solution with expertise, diagnosis and guidance under one roof. The unique R.I.S.C. test is something we have pioneered in India. It is a comprehensive, non-invasive and painless 7 min. procedure that measures 30 health parameters.At Lifespan, our diabetes specialists provide their undivided attention for a guaranteed 30 minute consultation; hence there is no time constraint. Further, there’s uniformity of treatment standards across all clinics that are designed to maximize convenience, therapy effectiveness and continuity of care and support.
How do your patients benefit from Lifespan Clinics?
Since Lifespan Clinics provides a unified solution with expertise, diagnosis and guidance under one roof, patients need not look further.The best part of Lifespan Clinics is the support that patients get all the time to adopt a healthier lifestyle, because as we like to tell them, the person who can help them win over diabetes is themselves.
How do you see Lifespan Clinics placed 5 years down the line? What are your future plans?
We are expanding on this concept of Comprehensive Diabetes Treatment Centres and extending the chain to all major cities across India. We have set ourselves a target of 1000 Lifespan Clinics across 20 major cities in India.
What is your business model, especially the franchisee led one?
As a franchisee, you would need to have approx 1000 sq. feet in an easily accessible location in the city or the suburbs. You should have the capacity to arrange for doctors and dieticians, and be able to invest Rs.15-30 lacs. Lifespan will only collect 20% of collections as Franchise Fee. We provide our franchises with the Lifespan R.I.S.C Test machine.
What would be the advantages for your franchisees of being associated with Lifespan India?
Good work always gives returns. As Diabetes is a major challenge & there are a huge number of diabetics, we expect a decent return on investment.We also provide media support, branding, call center support, software, back end support, field support, training, website, electronic medical records and other needed support.We build better brand value by advertising through Times of India which has a readership of over 76 lac. as per Indian Readership Survey (2012).We share with them the belief and commitment to extending the quality of our clientele’s health.
The Deal includes licensing out 20 innovative food supplements formulations to Dr. Datsons Labs to capture the flourishing $4 billion Neutraceutical Market in india.
Tuesday,20th January 2015, New Delhi : Belgium based Eubage Laboratory has striked a major partnership agreement with the Indian Pharma Company Dr. Datsons Labs Ltd specializing in Bulk drugs, Contract manufacturing Company which is the third-largest quinine salts manufacturer in the world and among the-largest controlled substances quota in India. As per the sources, Belgium Nutraceuticals giant Eubage Laboratory is expected to invest around Rs 100 crore in setting up a nutraceuticals manufacturing facility in the state of the art facility at Dr Datson’s UK-MHRA and EU-GMP-compliant facilities, & is ISO 9001:2008, ISO 14001:2004 and ISO 22000-certified Spanning 100,000 sq meters at unit at Mahad, Pune, India. Soon after the commissioning the plant & project by the Eubage Laboratory technical team next month. The plant initially will have a capacity of 200 tonnes annually and would scale up to 2,000 tonnes to cater to the domestic requirements of the country. Both the company are also in talks with various players in various parts of the world for exports of nutraceutical products wherever Belgium Nutraceuticals giant Eubage Laboratory is not present specially in middle east and it would be primarily to the European and other Asian countries. Pharmaceutical companies are the buyers for these products. Nutraceuticals is estimated to become $4 billion market in India by 2018 & the demand for this segment is growing with the forecast the Indian RTE food market is projected to grow at a CAGR of 22 per cent during 2014-19. With the passage of time and due to many international and local players in this segment, the percentage share rose with a rapid pace. Belgium company will license out 20 innovative food supplements formulations to Dr. Datsons Labs & will invest 100 Crore in Datson Labs Pune Factory. The Belgium delegation met the senior Board Members of Dr. Datsons Labs Ltd in Singapore to source some essential raw materials to be used for the finished formulations as the compositions in about six to seven products are not available in india. To confirm the news on this development, Pharmaleaders reached out to the promoters via mail/sms & voice, however, no one were available to comment till the release of this news, though the officials from the Eubage Laboratory confirmed the developments.
The collaboration & investment by Eubage Laboratory include 100 crore funding to the new project to Dr. Datsons Labs Ltd, a technology transfer agreement, license out 20 innovative food supplements formulations to Dr. Datsons Labs, a top Indian Pharma company to market the range of 20 products that include the revolutionary ingredients to be launched for the first time in india. Both Indian & Belgium Company will market the products by a top Indian Pharma company with a pan india base to reach out growing markets.
The Advantage Factors with Eubage Laboratory
amylase, proteases, papain, ficain, bromelain, cellulase
participates in the process of detoxification, drainage and the functioning of liver
participates in the stimulation and maintenance of memory and cognitive functions from students to seniors
promotes urinary comfort, regular micturitions and creates a hostile environment to micro-organisms
ensures an optimal ionic absorption of calcium, magnesium and dietary minerals in order to keep a good acid-base balance
participates in carbohydrate conversion and balanced glucose level
participates in emotional moderation, inducing better mental provisions, fast recovery and greater attention
participates in the removal of the heavy legs effect, swollen and sensitive reducing aqueous excess in lower limbs
regroups the most powerful antioxidants stimulating natural defenses and reducing the effects of lipid peroxides.
helps to reduce the uncomfortable effects of premenopause and menopause
contributes to a better resistance to menopausal effects by different phytoestrogens
helps to support an hormonal balance and a comfortable premenopause menopause by providing phytoprogesterones
participates in the intensification and endurance of men performances
participates in the protection of organic tissues and sustains the body reactivity during inflammation
participates in comfortable diuresis of men
participates to faster physical recovery and efficient cognitive functions
participates in an optimal cholesterol level and reduces the effects of triglycerides
improves metabolic provisions under stress and sustains concentration and memory
participates in strengthening antioxidant defenses and to improve the visual acuity
helps to maintain lubricated, flexible and protected joints
sustains skeleton by mineralization and maintenance of bone density
According to experts, nutraceuticals & functional foods would help mitigate malnutrition in India. Although, there is a huge potential for the growth of the sector, yet its development is slow. The country has a long way to go to en-cash much of its bio-agri wealth.
Speaking to Mr. Satya Brahma, Editor-In-Chief, Pharmaleaders Group, on the reason of investing in an Indian Company, Mr. Francois Liccope, CEO, Eubage Laboratories said, “there has been an increasing awareness among the rising affluent middle class about health and wellness. Nearly 400 million people in India belong to the middle class and have disposable income which have made them capable of buying nutraceuticals and dietary supplements. It is an inevitable fact that affluence is one of the causes of lifestyle diseases, which nutraceuticals and dietary supplements often address. These factors will support the double digit growth of the industry in the coming few years”. Nutraceuticals could complement drugs and can reduce over-dependence on medicines for treatment. There is considerable scope for value-addition of agri-by products. The biodiversity and traditional knowledge could make India a world leader in nutraceutical market.
Speaking on the scientific & technical edge over other players, Francois said “Eubage Laboratory develops its know-how and expertise to ensure reliable, efficient and traceable, productions. It has a Careful selection of raw materials & a highly trained Team of dedicated and approved professionals. Totally independent of any pharmaceutical group, Eubage Laboratory is distinguished by its flexibility and responsiveness. The Eubage ranges are marketed in several European countries under different types of representation, and preferred collaborations are established with partners for the distribution of those productions under our own brand or under the label of the distributor. Scientific and trade services of Eubage Laboratory are available for any feasibility study, in different dosage forms.Eubage Laboratory provides an advanced response to ethical nutrient and nutritional supplement markets throughout various countries. Our Innovation: The Catalyst C89 Enzymes are biological catalysts involved in many reactions essential for the proper functioning of a living organism. These macromolecules of proteins or RNA specifically recognize several molecules and accelerate transforming reactions to made their speed consistent with the functioning of the organism: they are biological catalysts, or biocatalysts. Enzyme activity regulation can normalize cellular metabolism. This activity depends strongly on the conformation of the enzyme, and thus of the shape of its sites, which can be modified via phosphorylation and dephosphorylation.Convergence point of several catabolic reactions of cellular metabolism, discovered by the biologistHans Adolf Krebs in 1937, the “Krebs Cycle” is a series biochemical reactions whose purpose is to produce energy feedstocks which will be used for ATP production in the respiratory chain. Composed of 8 steps each of which is catalyzed by a specific enzyme active during processing a chemical reaction in order to change its rate of reaction, both homogeneous and heterogeneous, in aerobic conditions, these enzymes, localized in the mitochondrial matrix or at the inner mitochondrial membrane, catalyze this reaction sequence. The Krebs Cycle is the ultimate degradation process of different metabolites.
Dietary supplements are the largest category accounting for 64 per cent of the nutraceuticals market, driven primarily by the pharmaceutical sector in the form of vitamin and mineral supplements. Functional foods will be the quickest growing category until 2015 followed by dietary supplements.However, dietary supplements, specifically herbal and dietetic supplements, will form the greatest opportunity areas for nutraceutical manufacturers, driven by growing demand from an evolving consumer base. Most of the leading pharmaceuticals companies have ventured into nutrition and nutraceuticals space and have a growing portfolio of such products which targets various therapeutic segments. This trend is increasingly on the rise and will continue to grow to a large extent in turn adding to the growth of the nutraceuticals industry.
With the growing popularity of these supplemented foods, many multinationals are investing in the nutraceuticals market in India. These include Monsanto, American Home Products, DuPont, BioCorrex, Abbott Laboratories, GlaxoSmithKline Consumer Healthcare, Johnson & Johnson, Nestle, Novartis, Yakult-Danone India, Herbalife etc. These players are a major resource for nutraceuticals and related dietary supplements. Besides, India has many local players such as Dabur India, Cadila Healthcare, British Biologicals, Himalaya Global Holdings, Sami Labs, Sami Direct, Parry Nutraceuticals, Wockhardt etc.
The global demand for nutraceutical ingredients is forecast to rise 7.2 per cent annually to $30 billion in 2017 according. The best growth prospects will exist in substances with clinically supported health benefits and broad applications in foods, beverages, dietary supplements and adult and pediatric nutritional preparations.
Countries such as Brazil, China, India, Mexico and Turkey will be among the fastest growing consumers and producers of nutraceutical ingredients worldwide. Increasing economic prosperity will enable these countries to expand and diversify their food and beverage, processing, and pharmaceutical industries. In 2017, China, alone, will absorb more than 16 per cent of the value of global nutraceutical ingredient demand and will account for over 18 per cent of the value of related world shipments. Because of maturing markets, the supply and demand of nutraceutical ingredients in the United States, Western Europe, and other developed economies will increase more slowly than the average worldwide pace. Nonetheless, food, beverage and pharmaceutical companies in these economies will continue to pursue opportunities in conventional and speciality nutritional products and natural medicines. As a result, they will remain key customers for nutraceutical ingredients.
Nutrients, including proteins, fibres and various specialized functional additives, will remain the top-selling group of nutraceutical ingredients worldwide. Proteins will post the fastest demand gains as food and beverage makers throughout the world will introduce new high value-added nutritional preparations. Functional additives and fibre nutrients will also fare well in the global marketplace.Demand for these ingredients will gain upward momentum from increasing clinical evidence of health benefits and expanding applications in speciality foods and beverages.Naturally derived substances, consisting of herbal and botanical extracts and animal- and marine-based derivatives, will see the fastest growth among the three major groups of nutraceutical ingredients. Among these substances, omega fatty acids derived from fish oils and other marine sources will lead gains, reflecting clinically proven cardiovascular benefits and expanding use in dietary supplements and nutritional therapies.
The rising popularity of preventive medicine will impact favourably on global demand for numerous other natural extracts and derivatives, including cranberry, garlic, ginkgo biloba, ginseng; and glucosamine and chondroitin.Well established applications in food and beverage fortification; infant, adult, and paediatric nutritionals; and dietary supplements will continue to be a large global market for mineral and vitamin ingredients. Within this group, essential minerals such as calcium, along with vitamin A and vitamin C substances, will post the fastest gains in world demand.
Pharmaleaders survey indicated that there are more than 8,000 registered and non-registered nutraceuticals, herbs and related companies in India but most of them are small and medium enterprises. The increasing need for additional nutrition and food security concerns in India has resulted in government to introduce schemes for vitamin fortification.
Overall, the Indian nutraceutical market is emerging with strong growth potential. With increasing health awareness, and the shift towards preventative health care and increased regulatory clarity, India’s future in nutraceuticals industry looks promising, for both manufacturers and consumers. However, there is a strong need of developing customized products, affordable pricing and distribution strategy. Though India holds only 10 per cent market share in the global nutraceutical market that will be a $250 billion industry by 2018, the country has a definite edge over China, which is the first rank holder in the industry, with better research and quality compliance. Industry experts point out that as the world back off from buying food supplements and nutraceuticals from China due to pollution and quality issues, India has a great advantage in the global market. The term Nutraceutical is applied to products that range from isolated nutrients, dietary supplements and herbal products, specific diets and processed foods such as cereals, soups, and beverages.
Though the annual growth rate of the industry is 7 per cent, in India it is growing at around 20 per cent annually. The country has a huge potential in this segment as 7,000 medicinal plants were identified in the country, but nutraceutical properties of majority of these plants remain untapped. The products from India are being exported to the US, Europe and Far East Asian countries.“As the quality standards in the US and Europe have been increasing continuously, China is losing its grip due to pollution and contamination problems. Even though China produces at least 10 times more these products, in terms of quality parameters India is far ahead. The awareness about the side effects of drugs is increasing drastically around the world which throws up good opportunities for Nutraceuticals and India. If we invest more on research, we could be a super power in the sector,” said Francois. Nutraceuticals are the exaggerated version of Ayurveda in which India has surely an upper hand. Companies from India are making strides in this market and the global presence of Indian products has been increasing recently.China is presently the second largest consumer and largest producer of the Nutraceuticals in the world. On the other hand, countries such as South Korea and Australia have also noticed an increasing growth trajectory in the Nutraceuticals market.
About Eubage Laboratory
Eubage Health Innovation is a trademark which develops and markets food supplements under its own brand and under the brand of third parties. From articulation to inflammation, from ophthalmology to stress, from menopause to urinary comfort, we are active in various therapeutic areas. The entire range is based on enzymology. An enzymatic complex that increases the bioavailability of different nutrients is added in each of our formulations. This enzymatic complex has obtained positive pre clinical results. Those trials have been done by the University of Liege. These products are registered by the Belgian Health Ministry and have obtained the authorizations needed in other European countries like France (DGCCRF), Portugal, Lithuania,… and abroad like Pakistan, Vietnam.Eubage Laboratory develops, manufactures and markets a broad range of optimal quality ethical nutrients and nutritional supplements. These realizations confirm the best guarantee in terms of analysis, traceability and purity of raw materials respecting the good manufacturing practices established (GMP). Eubage Laboratory develops, produces and markets ethical nutrients and nutritional supplements of pharmaceutical quality. By strictly adhering to the pharmaceutical industry’s good manufacturing processes (GMP), Eubage laboratory offers the strongest guaranties in terms of analysis, traceability and purity of all raw materials used in the development of exclusive formulas that guarantee an optimal result. Eubage Laboratory is a parapharmaceutical company based in Belgium which develops and markets food supplements under its own brand and under the brand of third parties. The company has launched twenty formulations and obtained from the competent authorities (SPF Santé Publique) its nutrients numbers. The entire range is based on enzymology. An enzymatic complex that increases the bioavailability of different nutrients is added in each of our formulations. This enzymatic complex has obtained positive pre clinical results. These products are registered with the APB (Belgian Pharmaceutical Association) and have obtained the authorizations needed in other European countries like France (DGCCRF).
About Dr. Datsons Lab Ltd
Dr. Datsons Lab Ltd, formerly known as Aanjaneya Lifecare Ltd, BSE code (533412) is a public listed vertically integrated company having state-of-the-art; WHO GMP approved facilities for manufacturing bulk drugs at Mahad and finished dosage forms at Pirungut near Pune. It is one of the largest contract manufacturers of codeine based cough syrups in India. The company exclusively manufactures the Codorex Brand of Zydus Cadilla and Codilite Brand of Tablets India Ltd. amongst others.The company raised about Rs. 117 crore from its IPO and the funds are being used to built new capacities along with the refurbishing of Research & Development centre. The new facilities being created as part of CAPEX are using eco friendly, recyclable material and will be rated by LEEDS once completed.The Facilities being established will comply with the latest European & US guidelines. With new capacities to be added in next 6 to 9 months the company will be expanding operations in emerging markets of South East Asia, Africa & South & Central America and its domestic operation in branded generics segment. The company with its manufacturing facilities –in Mahad, Hyderabad and Pune has to its credit many achievements. It is the world’s third-largest manufacturer of quinine salts in the world . Only nine companies globally manufacture quinine salts.One of the largest codeine based formlulations manufacturer in the pharmaceutical sector. One of the largest manufacturer of multi- flavored Lozenges in medical products in India. The company pioneered the recognition that lozenges represent a stable platform for the delivery of pharmaceutical and nutraceutical ingredients. Dr. Datson’s Nicco Nil lozenge is a first-of-its-kind hard boiled lozenge remedy for smoking de-addition; its Relacs is a first-time lozenge against insomnia and Arecta Plus, a lozenge variant for Erectile Dysfunction, is a first of its kind . The company has an expertise in opportunity spotting and innovation. The company’s success has been built on a business model that integrates Research, Innovation and Knowledge. The company has invested in building proprietary Knowledge through research and acquisitions. Dr. Datson’s competence has been validated through patents granted by international and Indian authorities. Production of Quinine Sulphate increased 30% in 2011-2012. Sales of Quinine Sulphate grew 45%. Exports increased 250% from Rs 10 Crore to Rs 31 crore. Added 35 international and 50 domestic clients. Completed trials for Bromexine(expectorant)a new API that will be launched in 2012-1023. Highlights 2011-2012 for Finished Dosage Forms. Launched ‘Rancorex’ an in-house codine based cough syrup brand for the first time in its history. received the Kenya PPB GMP approval from all facilities namely lozenges,liquids and ointments. Received registration for ‘Arecta Plus’(a lozenge variant of Viagra tablets)from Sierrs Leone and Libya; received the first export order for this product to be executed in 2012-2013.
Global Head – Communications